Compile Data Set for Download or QSAR
Report error Found 288 Enz. Inhib. hit(s) with all data for entry = 8614
TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 404241BDBM404241((2S,5R)-5-(2-chlorophenyl)-1-(2'-methoxy-4'-(N-met...)
Affinity DataEC50: <200nMAssay Description:The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM NaCl, 10 μg/ml saponin, 30 mM of MgCl2, 10 μM of GDP, 5 μg membra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 404236BDBM404236((2S,5R)-1-(2'-chloro-5'-cyano-[1,1'-biphenyl]-4-ca...)
Affinity DataEC50: <200nMAssay Description:The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM NaCl, 10 μg/ml saponin, 30 mM of MgCl2, 10 μM of GDP, 5 μg membra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 403773BDBM403773((2S,5R)-5-(2-chlorophenyl)-1-(4'-methyl-[1,1'-biph...)
Affinity DataEC50: <200nMAssay Description:The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM NaCl, 10 μg/ml saponin, 30 mM of MgCl2, 10 μM of GDP, 5 μg membra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 404237BDBM404237((2S,5R)-5-(2-chlorophenyl)-1-(2'-cyano-4'-(trifluo...)
Affinity DataEC50: <200nMAssay Description:The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM NaCl, 10 μg/ml saponin, 30 mM of MgCl2, 10 μM of GDP, 5 μg membra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 403786BDBM403786((2S,5R)-5-(2-chlorophenyl)-1-(3-methoxy-5-phenetho...)
Affinity DataEC50: <200nMAssay Description:The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM NaCl, 10 μg/ml saponin, 30 mM of MgCl2, 10 μM of GDP, 5 μg membra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 404240BDBM404240((2S,5R)-5-(2-chlorophenyl)-1-(2'-methyl-3'-(N-meth...)
Affinity DataEC50: <200nMAssay Description:The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM NaCl, 10 μg/ml saponin, 30 mM of MgCl2, 10 μM of GDP, 5 μg membra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 404231BDBM404231((2S,5R)-1-(2'-cyano-4'-methoxy-[1,1'-biphenyl]-4-c...)
Affinity DataEC50: <200nMAssay Description:The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM NaCl, 10 μg/ml saponin, 30 mM of MgCl2, 10 μM of GDP, 5 μg membra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 403752BDBM403752((2S,5R)-5-(2-chlorophenyl)-1-(2'-methoxy-[1,1'-bip...)
Affinity DataEC50: <200nMAssay Description:The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM NaCl, 10 μg/ml saponin, 30 mM of MgCl2, 10 μM of GDP, 5 μg membra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 403763BDBM403763((2S,5R)-5-(2-chlorophenyl)-1-(2'-methyl-[1,1'-biph...)
Affinity DataEC50: <200nMAssay Description:The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM NaCl, 10 μg/ml saponin, 30 mM of MgCl2, 10 μM of GDP, 5 μg membra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 403764BDBM403764((2S,5R)-1-(3-((4-chlorobenzyl)oxy)-5-methoxybenzoy...)
Affinity DataEC50: <200nMAssay Description:The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM NaCl, 10 μg/ml saponin, 30 mM of MgCl2, 10 μM of GDP, 5 μg membra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 403767BDBM403767((2S,5R)-5-(2-chlorophenyl)-1-(2'-fluoro-[1,1'-biph...)
Affinity DataEC50: <200nMAssay Description:The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM NaCl, 10 μg/ml saponin, 30 mM of MgCl2, 10 μM of GDP, 5 μg membra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 404228BDBM404228((2S,5R)-5-(2,3-difluorophenyl)-1-(2'-methoxy-[1,1'...)
Affinity DataEC50: <200nMAssay Description:The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM NaCl, 10 μg/ml saponin, 30 mM of MgCl2, 10 μM of GDP, 5 μg membra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 404229BDBM404229((2S,5R)-5-(2,5-difluorophenyl)-1-(2'-methoxy-[1,1'...)
Affinity DataEC50: <200nMAssay Description:The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM NaCl, 10 μg/ml saponin, 30 mM of MgCl2, 10 μM of GDP, 5 μg membra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 404254BDBM404254((2S,5R)-1-(5'-cyano-2'-methyl-[1,1'-biphenyl]-4-ca...)
Affinity DataEC50: <200nMAssay Description:The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM NaCl, 10 μg/ml saponin, 30 mM of MgCl2, 10 μM of GDP, 5 μg membra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 404212BDBM404212((2S,5R)-5-(2-chlorophenyl)-1-(2'-cyano-4'-methoxy-...)
Affinity DataKi: <200nMAssay Description:The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM NaCl, 10 μg/ml saponin, 30 mM of MgCl2, 10 μM of GDP, 5 μg membra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 404249BDBM404249((2S,5R)-5-(2-fluorophenyl)-1-(2'-methyl-3'-(N-meth...)
Affinity DataEC50: <200nMAssay Description:The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM NaCl, 10 μg/ml saponin, 30 mM of MgCl2, 10 μM of GDP, 5 μg membra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 404251BDBM404251((2S,5R)-5-(2-chlorophenyl)-1-(4-(4,6-dimethoxypyri...)
Affinity DataEC50: <200nMAssay Description:The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM NaCl, 10 μg/ml saponin, 30 mM of MgCl2, 10 μM of GDP, 5 μg membra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 404253BDBM404253((2S,5R)-5-(2,3-difluorophenyl)-1-(4-(2,4-dimethoxy...)
Affinity DataEC50: <200nMAssay Description:The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM NaCl, 10 μg/ml saponin, 30 mM of MgCl2, 10 μM of GDP, 5 μg membra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 404245BDBM404245((2S,5R)-1-(2'-cyano-4'-(trifluoromethyl)-[1,1'-bip...)
Affinity DataEC50: <200nMAssay Description:The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM NaCl, 10 μg/ml saponin, 30 mM of MgCl2, 10 μM of GDP, 5 μg membra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 404247BDBM404247((2S,5R)-1-(2'-chloro-5'-cyano-[1,1'-biphenyl]-4-ca...)
Affinity DataEC50: <200nMAssay Description:The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM NaCl, 10 μg/ml saponin, 30 mM of MgCl2, 10 μM of GDP, 5 μg membra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 404248BDBM404248((2S,5R)-5-(2-chlorophenyl)-1-(4-(3,6-dimethoxypyri...)
Affinity DataEC50: <200nMAssay Description:The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM NaCl, 10 μg/ml saponin, 30 mM of MgCl2, 10 μM of GDP, 5 μg membra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 408766BDBM408766(US10358416, Compound 385 | (2S,5R)-1-(1-(5-chloro-...)
Affinity DataKi: <200nMAssay Description:The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM NaCl, 10 μg/ml saponin, 30 mM of MgCl2, 10 μM of GDP, 5 μg membra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 403853BDBM403853((2S,5R)-5-(2-chlorophenyl)-1-(2',5'-dichloro-[1,1'...)
Affinity DataEC50: <200nMAssay Description:The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM NaCl, 10 μg/ml saponin, 30 mM of MgCl2, 10 μM of GDP, 5 μg membra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 403834BDBM403834((2S,5R)-5-(2-chlorophenyl)-1-(6-(2-chlorophenyl)ni...)
Affinity DataEC50: <200nMAssay Description:The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM NaCl, 10 μg/ml saponin, 30 mM of MgCl2, 10 μM of GDP, 5 μg membra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 403879BDBM403879((2S,5R)-5-(2-chlorophenyl)-1-(3'-(methylsulfonamid...)
Affinity DataEC50: <200nMAssay Description:The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM NaCl, 10 μg/ml saponin, 30 mM of MgCl2, 10 μM of GDP, 5 μg membra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 403881BDBM403881((2S,5R)-5-(2-chlorophenyl)-1-(4-(naphthalen-2-yl)b...)
Affinity DataEC50: <200nMAssay Description:The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM NaCl, 10 μg/ml saponin, 30 mM of MgCl2, 10 μM of GDP, 5 μg membra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 403868BDBM403868((2S,5R)-1-(4'-chloro-[1,1'-biphenyl]-4-carbonyl)-5...)
Affinity DataEC50: <200nMAssay Description:The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM NaCl, 10 μg/ml saponin, 30 mM of MgCl2, 10 μM of GDP, 5 μg membra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 403869BDBM403869((2S,5R)-1-(3'-chloro-[1,1'-biphenyl]-4-carbonyl)-5...)
Affinity DataEC50: <200nMAssay Description:The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM NaCl, 10 μg/ml saponin, 30 mM of MgCl2, 10 μM of GDP, 5 μg membra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 403873BDBM403873((2S,5R)-1-(2'-chloro-[1,1'-biphenyl]-4-carbonyl)-5...)
Affinity DataEC50: <200nMAssay Description:The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM NaCl, 10 μg/ml saponin, 30 mM of MgCl2, 10 μM of GDP, 5 μg membra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 403878BDBM403878((2S,5R)-5-(2-chlorophenyl)-1-(4'-(methylsulfonamid...)
Affinity DataEC50: <200nMAssay Description:The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM NaCl, 10 μg/ml saponin, 30 mM of MgCl2, 10 μM of GDP, 5 μg membra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 403865BDBM403865((2S,5R)-5-(2-chlorophenyl)-1-(4-(2-methoxypyridin-...)
Affinity DataEC50: <200nMAssay Description:The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM NaCl, 10 μg/ml saponin, 30 mM of MgCl2, 10 μM of GDP, 5 μg membra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 403866BDBM403866((2S,5R)-5-(2-chlorophenyl)-1-(4'-methoxy-[1,1'-bip...)
Affinity DataEC50: <200nMAssay Description:The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM NaCl, 10 μg/ml saponin, 30 mM of MgCl2, 10 μM of GDP, 5 μg membra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 403907BDBM403907((2S,5R)-1-(4-benzylbenzoyl)-5-(2-chlorophenyl)pyrr...)
Affinity DataEC50: <200nMAssay Description:The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM NaCl, 10 μg/ml saponin, 30 mM of MgCl2, 10 μM of GDP, 5 μg membra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 403889BDBM403889((2S,5R)-5-(2-chlorophenyl)-1-(2'-isopropoxy-[1,1'-...)
Affinity DataEC50: <200nMAssay Description:The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM NaCl, 10 μg/ml saponin, 30 mM of MgCl2, 10 μM of GDP, 5 μg membra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 403891BDBM403891((2S,5R)-5-(2-chlorophenyl)-1-(2'-(cyclopropylmetho...)
Affinity DataEC50: <200nMAssay Description:The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM NaCl, 10 μg/ml saponin, 30 mM of MgCl2, 10 μM of GDP, 5 μg membra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 403884BDBM403884((2S,5R)-5-(2-chlorophenyl)-1-(2'-(trifluoromethoxy...)
Affinity DataEC50: <200nMAssay Description:The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM NaCl, 10 μg/ml saponin, 30 mM of MgCl2, 10 μM of GDP, 5 μg membra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 403927BDBM403927((2S,5R)-5-(2-chlorophenyl)-1-(4-(3-methoxypyridin-...)
Affinity DataEC50: <200nMAssay Description:The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM NaCl, 10 μg/ml saponin, 30 mM of MgCl2, 10 μM of GDP, 5 μg membra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 403909BDBM403909((2S,5R)-5-(2-chlorophenyl)-1-(4-(2,4-dimethoxypyri...)
Affinity DataEC50: <200nMAssay Description:The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM NaCl, 10 μg/ml saponin, 30 mM of MgCl2, 10 μM of GDP, 5 μg membra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 403946BDBM403946((2S,5R)-1-(2'-chloro-2-methoxy-[1,1'-biphenyl]-4-c...)
Affinity DataEC50: <200nMAssay Description:The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM NaCl, 10 μg/ml saponin, 30 mM of MgCl2, 10 μM of GDP, 5 μg membra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 403949BDBM403949((2S,5R)-5-(2-chlorophenyl)-1-(4-(2-methylthiophen-...)
Affinity DataEC50: <200nMAssay Description:The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM NaCl, 10 μg/ml saponin, 30 mM of MgCl2, 10 μM of GDP, 5 μg membra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 403960BDBM403960((2S,5R)-5-(2-chlorophenyl)-1-(2',6'-dichloro-[1,1'...)
Affinity DataEC50: <200nMAssay Description:The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM NaCl, 10 μg/ml saponin, 30 mM of MgCl2, 10 μM of GDP, 5 μg membra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 403941BDBM403941((2S,5R)-5-(2-chlorophenyl)-1-(2',4'-dimethoxy-[1,1...)
Affinity DataEC50: <200nMAssay Description:The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM NaCl, 10 μg/ml saponin, 30 mM of MgCl2, 10 μM of GDP, 5 μg membra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 403945BDBM403945((2S,5R)-1-(2-chloro-[1,1'-biphenyl]-4-carbonyl)-5-...)
Affinity DataEC50: <200nMAssay Description:The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM NaCl, 10 μg/ml saponin, 30 mM of MgCl2, 10 μM of GDP, 5 μg membra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 403937BDBM403937((2S,5R)-5-(2-chlorophenyl)-1-(2'-(trifluoromethyl)...)
Affinity DataEC50: <200nMAssay Description:The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM NaCl, 10 μg/ml saponin, 30 mM of MgCl2, 10 μM of GDP, 5 μg membra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 403938BDBM403938((2S,5R)-5-(2-chlorophenyl)-1-(2,2'-dimethoxy-[1,1'...)
Affinity DataEC50: <200nMAssay Description:The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM NaCl, 10 μg/ml saponin, 30 mM of MgCl2, 10 μM of GDP, 5 μg membra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 403939BDBM403939((2S,5R)-1-(4'-chloro-2'-methoxy-[1,1'-biphenyl]-4-...)
Affinity DataEC50: <200nMAssay Description:The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM NaCl, 10 μg/ml saponin, 30 mM of MgCl2, 10 μM of GDP, 5 μg membra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 403931BDBM403931((2S,5R)-5-(2-chlorophenyl)-1-(2-methoxy-[1,1'-biph...)
Affinity DataEC50: <200nMAssay Description:The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM NaCl, 10 μg/ml saponin, 30 mM of MgCl2, 10 μM of GDP, 5 μg membra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 403932BDBM403932((2S,5R)-5-(2-chlorophenyl)-1-(2'-cyano-[1,1'-biphe...)
Affinity DataEC50: <200nMAssay Description:The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM NaCl, 10 μg/ml saponin, 30 mM of MgCl2, 10 μM of GDP, 5 μg membra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 403933BDBM403933((2S,5R)-5-(2-chlorophenyl)-1-(2',6'-dimethoxy-[1,1...)
Affinity DataEC50: <200nMAssay Description:The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM NaCl, 10 μg/ml saponin, 30 mM of MgCl2, 10 μM of GDP, 5 μg membra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Epics Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 403936BDBM403936((2S,5R)-5-(2-chlorophenyl)-1-(2',4'-dichloro-[1,1'...)
Affinity DataEC50: <200nMAssay Description:The [35S]GTPγS assay was incubated in 20 mM HEPES pH7.4, 100 mM NaCl, 10 μg/ml saponin, 30 mM of MgCl2, 10 μM of GDP, 5 μg membra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

Displayed 1 to 50 (of 288 total ) | Next | Last >>
Jump to: